{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:34:32Z","timestamp":1763706872049,"version":"3.37.3"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970883"],"award-info":[{"award-number":["31970883"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110141","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T22:35:16Z","timestamp":1725748516000},"page":"110141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Distinct functional diversity of branched oligosaccharides as chaperones and inhibitory-binding partners of amyloid beta-protein and its aggregates"],"prefix":"10.1016","volume":"261","author":[{"given":"He","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110141_bib1","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/jnr.22393","article-title":"Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies\u2014a review","volume":"88","author":"Ariga","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2024.110141_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073502","article-title":"Dietary influences on the microbiota\u2013gut\u2013brain Axis","volume":"22","author":"Barber","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110141_bib3","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1046\/j.1471-4159.1997.69062452.x","article-title":"Perlecan binds to the \u03b2\u2010amyloid proteins (A\u03b2) of Alzheimer's disease, accelerates A\u03b2 fibril formation, and maintains A\u03b2 fibril stability","volume":"69","author":"Castillo","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110141_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","article-title":"Functions of A\u03b2, sAPP\u03b1 and sAPP\u03b2 : similarities and differences","volume":"120","author":"Chasseigneaux","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110141_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tibs.2006.05.001","article-title":"Molecular chaperones: assisting assembly in addition to folding","volume":"31","author":"Ellis","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2024.110141_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13061","article-title":"Pathological changes within the cerebral vasculature in Alzheimer's disease: new perspectives","volume":"32","author":"Fisher","year":"2022","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2024.110141_bib7","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1074\/jbc.M008128200","article-title":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development","volume":"276","author":"Fraser","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110141_bib8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archneur.60.7.958","article-title":"Age but not diagnosis is the main predictor of plasma amyloid \u03b2-protein levels","volume":"60","author":"Fukumoto","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110141_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110112","article-title":"Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease","volume":"106","author":"Goyal","year":"2021","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110141_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbamem.2013.07.018","article-title":"Interaction of membrane\/lipid rafts with the cytoskeleton: impact on signaling and function","volume":"1838","author":"Head","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.neuropharm.2024.110141_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymgme.2017.12.428","article-title":"Chaperone effect of sulfated disaccharide from heparin on mutant iduronate-2-sulfatase in mucopolysaccharidosis type II","volume":"123","author":"Hoshina","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.neuropharm.2024.110141_bib12","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1046\/j.1432-1033.2002.03145.x","article-title":"Chaperone and antichaperone activities of trigger factor","volume":"269","author":"Huang","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuropharm.2024.110141_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneumeth.2009.10.026","article-title":"Recombinant GST-I-A\u03b228-induced efficient serum antibody against A\u03b242","volume":"186","author":"Huang","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2024.110141_bib14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110141_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118627","article-title":"Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease","volume":"264","author":"Kesika","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2024.110141_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10571-015-0256-9","article-title":"Endothelial dysfunction and amyloid-\u03b2-induced neurovascular alterations","volume":"36","author":"Koizumi","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110141_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jdermsci.2016.05.016","article-title":"Glycosaminoglycan and proteoglycan in skin aging","volume":"83","author":"Lee","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110141_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010037","article-title":"The microbiota\u2013gut\u2013brain Axis and Alzheimer's disease: neuroinflammation is to blame?","volume":"13","author":"Megur","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2024.110141_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071884","article-title":"Cellular receptors of amyloid \u03b2 oligomers (A\u03b2Os) in Alzheimer's disease","volume":"19","author":"Mroczko","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110141_bib20","series-title":"Lehninger Principles of Biochemistry","first-page":"1101","author":"Nelson","year":"2008"},{"key":"10.1016\/j.neuropharm.2024.110141_bib21","series-title":"Lehninger Principles of Biochemistry","first-page":"257","author":"Nelson","year":"2008"},{"key":"10.1016\/j.neuropharm.2024.110141_bib22","doi-asserted-by":"crossref","first-page":"980S","DOI":"10.1093\/jn\/127.5.980S","article-title":"Do the binding properties of oligosaccharides in milk protect human infants from gastrointestinal bacteria?","volume":"127","author":"Newburg","year":"1997","journal-title":"J. Nutr."},{"key":"10.1016\/j.neuropharm.2024.110141_bib23","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.fshw.2023.02.042","article-title":"Degradation of amyloid \u03b2-peptides catalyzed by nattokinase in vivo and in vitro","volume":"12","author":"Ni","year":"2023","journal-title":"Food Sci. Hum. Wellness"},{"key":"10.1016\/j.neuropharm.2024.110141_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0167-4838(00)00041-8","article-title":"Structure, specificity and function of cyclomaltodextrinase, a multispecific enzyme of the alpha-amylase family","volume":"1478","author":"Park","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2024.110141_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clnesp.2024.02.019","article-title":"Gut instincts: unveiling the connection between gut microbiota and Alzheimer's disease","volume":"60","author":"Peddinti","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2024.110141_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/jcs.113.2.193","article-title":"Synthesis and sorting of proteoglycans","volume":"113","author":"Prydz","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2024.110141_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2019.1651157","article-title":"The extracellular matrix of the blood\u2013brain barrier: structural and functional roles in health, aging, and Alzheimer's disease","volume":"7","author":"Reed","year":"2019","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.neuropharm.2024.110141_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3746\/pnf.2024.29.2.93","article-title":"Current research on the role of isomaltooligosaccharides in gastrointestinal health and metabolic diseases","volume":"29","author":"Rini","year":"2024","journal-title":"Preventive Nutr. Food Sci."},{"key":"10.1016\/j.neuropharm.2024.110141_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2024.110141_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020690","article-title":"Crosstalk between gut and brain in Alzheimer's disease: the role of gut microbiota modulation strategies","volume":"13","author":"Shabbir","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2024.110141_bib31","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1007\/s12035-023-03406-8","article-title":"Dual efficacy of a catalytic anti-oligomeric A\u03b242 scFv antibody in clearing A\u03b242 aggregates and reducing A\u03b2 burden in the brains of Alzheimer's disease mice","volume":"60","author":"Song","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110141_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196751","article-title":"Conformational essentials responsible for neurotoxicity of A\u03b242 aggregates revealed by antibodies against oligomeric A\u03b242","volume":"27","author":"Song","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110141_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200191","article-title":"Design and synthesis of 6\u2010O\u2010phosphorylated heparan sulfate oligosaccharides to inhibit amyloid \u03b2 aggregation","volume":"23","author":"Uchimura","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.neuropharm.2024.110141_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(02)01759-4","article-title":"Low molecular weight glycosaminoglycan blockade of \u03b2-amyloid induced neuropathology - ScienceDirect","volume":"445","author":"Walzer","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110141_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2018.11.005","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2024.110141_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2023.108891","article-title":"Synthesis of mannan oligosaccharide-sialic acid conjugates and its inhibition on A\u03b242 aggregation","volume":"531","author":"Wu","year":"2023","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.neuropharm.2024.110141_bib37","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1002\/jsfa.13394","article-title":"Oligosaccharides from black ginseng innovatively prepared by low\u2010temperature steam\u2010heating process ameliorate cognitive impairment in Alzheimer's disease mice via the Keap\u20101\/Nrf2 pathway","volume":"104","author":"Xu","year":"2024","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.neuropharm.2024.110141_bib38","article-title":"Chitosan oligosaccharides inhibit\/disaggregate fibrils and attenuate amyloid \u03b2-mediated neurotoxicity","author":"Xueling","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110141_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104746","article-title":"Nonlinear and mixed inhibitory effect of matrine on the cytotoxicity of oligomeric amyloid-\u03b2 protein","volume":"137","author":"Yang","year":"2020","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110141_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-022-01219-2","article-title":"Extracellular amyloid \u03b2-protein (1-42) oligomers anchor brain cells and make them inert as an unconventional integrin-coupled ligand","volume":"43","author":"Zhang","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110141_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.intimp.2018.12.014","article-title":"Novel antibody against oligomeric amyloid-\u03b2: insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-\u03b2 aggregates","volume":"67","author":"Zhang","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2024.110141_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2015.07.038","article-title":"The protective effects and underlying mechanism of an anti-oligomeric A\u03b242 single-chain variable fragment antibody","volume":"99","author":"Zhang","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110141_bib43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s12640-018-9955-6","article-title":"The mode of action of an anti-oligomeric amyloid \u03b2-protein antibody affects its protective efficacy","volume":"35","author":"Zhang","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2024.110141_bib44","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s12035-014-8910-7","article-title":"Functional characteristics and molecular mechanism of a new scFv antibody against A\u03b242 oligomers and immature protofibrils","volume":"52","author":"Zhang","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110141_bib45","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1039\/D4FO00421C","article-title":"Dietary supplementation with non-digestible isomaltooligosaccharide and Lactiplantibacillus plantarum ZDY2013 ameliorates DSS-induced colitis via modulating intestinal barrier integrity and the gut microbiota","volume":"15","author":"Zhang","year":"2024","journal-title":"Food Funct."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:56:33Z","timestamp":1730865393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S0028390824003101"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110141","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct functional diversity of branched oligosaccharides as chaperones and inhibitory-binding partners of amyloid beta-protein and its aggregates","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110141"}}